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Abstract
Background: In recent years, measuring and evaluating the efficiency of health systems has been explored in the
context of seeking resources to ensure the sustainability of ‘countries’ health and social systems and addressing
various crises in the health sector. The study aims to quantify and compare the efficiency of OECD health systems
in 2000, 2008, and 2016. The contribution to research in the field of efficiency in the healthcare system can be seen
in the application of Dynamic Network Data Envelopment Analysis (DNDEA), which help us to analyse not only the
overall efficiency of the healthcare system but analyse the overall efficiency as the result of the efficiencies of
individual interconnected areas (public and medical care area). By applying the DNDEA model, we can realise the
analysis not only within one year, but we can find out if the measures and improvements taken in the healthcare
sector have a positive impact on its efficiency in a later period (eight-year interval).
Methods: The analysis focuses on assessing the efficiency of the health systems of OECD countries over three
periods: 2000, 2008, and 2016. Data for this study were derived from the existing OECD database, which provides
aggregated data on OECD countries on a comparable basis. In this way, it was possible to compare different
countries whose national health statistics may have their characteristics. The input-oriented Dynamic Network Data
Envelopment Analysis model was used for data processing. The efficiency of OECD health systems has been
analysed and evaluated comprehensively and also separately in two divisions: public health sub-division and
medical care sub-division. The analysis combines the application of conventional and unconventional methods of
measuring efficiency in the health sector.
Results: The results for the public health sub-division, medical care sub-division and overall health system for OECD
countries under the assumption of constant returns to scale indicate that the average overall efficiency was 0.8801
in 2000, 0.8807 in 2008 and 0.8472 in 2016. The results of the input-oriented model with the assumption of
constant returns to scale point to the overall average efficiency of health systems at the level of 0.8693 during the
period. According to the Malmquist Index results, the OECD countries improved the efficiency over the years, with
performance improvements of 19% in the public health division and 8% in the medical care division.
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Conclusions: The results of the study are beneficial for health policymakers to assess and compare health systems
in countries and to develop strategic national and regional health plans. Similarly, the result will support the
development of international benchmarks in this area. The issue of health efficiency is an intriguing one that could
be usefully explored in further research. A greater focus on combining non-parametric and parametric models
could produce interesting findings for further research. The consistency in the publication and updating of the data
on health statistics would help us establish a greater degree of accuracy.
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Introduction
In the last three decades, many significant changes in
the health sector, mainly affected by the global ageing
process, were evident. It impacts the present state of
health systems in the individual countries and their sus-
tainability. The international organisations, such as the
WHO, OECD, Eurostat and others, also play a partial
role. These organisations emphasise the quality and
availability of health services and a fair way of financing
and investments in this field. Healthcare is one of the
areas of the public sector where more funding does not
automatically mean better results or improvement of the
population’s health condition [1]. The use of optimal
measurement systems will not only measure and evalu-
ate the efficiency of individual interventions in health
systems and relevant policies, but it will also create
benchmarking indicators for comparing health systems
across multiple countries. To maximise the positive im-
pact, effective health management needs to consider sev-
eral aspects such as financing, the healthcare market,
structure and regulatory stabilisation mechanisms. The
present upwards trend of computerisation of society and
technological progress only highlights the importance of
improving performance measurement in healthcare. The
main concern of health policymakers and managers are
the efforts to measure efficiency [2], with many countries
having introduced reforms to improve health systems
over the past three decades [3, 4]. Several studies con-
clude that the main issue in all health systems is ineffi-
ciency [5–8]. WHO [6] claims that there are evident
global differences in the efficiency of health systems.
The main issue is in finding optimal methods to meas-
ure health efficiency and how they may apply to good
policy or management decisions.
Measurement of health efficiency is often very compli-
cated due to external factors, including social determi-
nants of health. Many of these factors cannot be affected
by the health sector. Therefore, any efficiency measure
in this area must take into account the impact of exter-
nal factors. Cylus et al. [9] state that there are effectively
functioning components within an inefficient health sys-
tem. An example is the hospital sector and/or parts
thereof. While the authors remind us that the hospital
sector may be efficient, it is very likely that hospitals can
also operate in an extremely inefficient health system. In
this area, preventive health measures may not receive
sufficient attention or lack of primary health care.
Therefore, we emphasise the importance of monitoring
several health system levels to determine the nature and
extent of inefficiency.
Measuring health efficiency is a challenging process
that involves two groups of risks: scepticism in identify-
ing and finding ways to eliminate the inefficiency of the
health system and improperly set strategies that may in-
efficiently reduce spending in high-efficiency areas of the
system. Efficiency, not only in healthcare but also in the
economy, is important for national leaders to set finan-
cial stability, long-term economic sustainability, and in-
crease competitiveness.
Generally, there are many interrelated processes in
the health system that may be evaluated independently.
To ensure best practice, it is possible to determine
whether these processes are effective or ineffective. A
large number of indicators are monitored in the health
system to identify and quantify inefficiency. However,
the interpretation of many of them in a comprehensive
assessment of health efficiency may be quite
questionable.
It is hoped that this work will lead to new insights of
further development of methods for assessing efficiency
and examining their limitations, not only from their
process but also from the perspective of outputs and
their implementation in relevant policies. This consistent
fact has also prompted this research to examine the effi-
ciency of health systems in OECD countries during
2000, 2008 and 2016 in two areas: public health and
medical care. The findings of the analyses will provide a
valuable platform for national health policymakers and
support the development of international and national
benchmarks in this field.
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Literature review
The sustainable pressure on the proper use of resources
in the health sector has led the main actors and policy-
makers to look for efficient ways of delivering health ser-
vices. Any improvement in the health system, although
incrementally, may bring significant savings in financial
resources. Effective healthcare should be a priority for
governments in all countries. The analysis of the effi-
ciency of health systems compared to other sectors is
much more complicated due to the heterogeneity of
health processes, the provision of health services and the
determinants of the healthcare market in all countries.
Several methods are used to assess the efficiency of
health systems in research studies, while Data Envelop-
ment Analysis (DEA) and Stochastic Frontier Analysis
(SFA) have been widely reported and extensively ex-
plored in the past three decades [10].
Ozcan [5] has shown that classical comparative
methods and models based on ratios bring more compli-
cations than solutions. According to the author, the
evaluation of organisational unit efficiency should be
based on optimisation techniques and their normative
structure while providing reference criteria and a way to
improve the efficiency of lagging organisational units.
Each organisational unit requires an individual form of
efficiency assessment. The optimal combination of in-
puts and outputs plays an important role (e.g. [11]). Re-
garding efficiency, the quality of provided healthcare is
also linked, and a relationship between these two cat-
egories is examined in several dimensions.
Singaroyan et al. [12] concluded that improving
healthcare quality does not always lead to effective pro-
cesses. Mobley & Magnussen [13] have shown that poor
performance in healthcare is due to low efficiency. Hel-
ling et al. [14] confirmed that increasing the efficiency
rate also increases the quality of provided healthcare.
There exists a very extensive literature on the topic of
the ability of individual health systems to transform re-
sources into desired outcomes. However, their common
feature is identifying areas that produce inefficiency in
health systems, leading to excessive spending on health.
A common feature of these studies is applying the
DEA to estimate the relative technical efficiency of
health systems. Retzlaff-Roberts et al. [15] used an input-
and output-oriented model with the assumption of a
variable returns to scale (VRS). Bhat [16] used an input-
oriented DEA model based on the assumption of the
constant returns to scale (CRS). Adang & Borm [17] per-
formed the output-oriented DEA using CRS model and
supported the analysis with results of the Malmquist
Index. Li et al. [18] calculated the efficiency score based
on an input-oriented DEA model with CRS in a specific
group of transition economies, comparing the results
with the OECD countries. Zeng et al. [19] applied an
output-oriented DEA model with the specific weight
boundaries for outputs to calculate the technical effi-
ciency of individual HIV/AIDS prevention programs.
Medeiros & Schwierz [20] used the DEA model with the
VRS based on the work of Hollingsworth & Smith [10].
They also performed the SFA and bootstrapping ap-
proaches in their analysis. Li et al. [18] conclude that ini-
tially, the research of health ‘systems’ efficiency
measurement was focused more on an organisational or
corporate level (e.g. hospitals or health institutions; Kohl
et al. [21] in their extensive study investigated 262 scien-
tific articles in this area).
Drawing on an extensive range of sources, these stud-
ies set out similar ways to select inputs and outputs.
With this in mind, we describe selected variables, which
are also used in our analysis. On the input side, the per
capita health expenditure (in US$ in PPP, or expressed
as a per cent of GDP), the number of physicians per
1000 inhabitants or tobacco consumption are often used.
The importance of selecting the indicator of health ex-
penditure in measuring the efficiency in the health sec-
tor is also investigated by Blendon et al. [22, 23]. The
number of physicians per 1000 people and its import-
ance is also commented on by Grubaugh & Santerre
[24]. Contoyannis & Jones [25] and Shaw et al. [26] have
also reported tobacco consumption as an important in-
dicator in the health field. However, there is a great deal
of debate surrounding alcohol consumption (measured
in litres per capita) involving this indicator in the ana-
lysis. For instance, Conotyannis & Jones [25] have not
shown a significant effect of alcohol consumption on life
expectancy at birth (LE), neither Adang & Borm [17],
Retzlaff-Roberts et al. [15].
Nevertheless, Li et al. [18] include this indicator in
their analyses. On the other side, Bhat [16] demon-
strated by Spearman’s correlation coefficient that alcohol
and tobacco consumption impact the level of health.
The outputs are life expectancy at birth, infant mortality
rate, and/or avoidable mortality in several studies.
The causes of missing data have been the subject of
intense debate within the scientific community. Gru-
baugh & Santerre [24] recommend using a smaller sam-
ple of countries for comparison and not including the
country with missing data in the analysis. On the other
hand, Anderson et al. [27], indicate a possibility of using
data that are the closest to a reference year or a period
for which the analysis is realised. As mentioned above,
an important part of health efficiency analysis is the
proper selection of inputs and outputs and subsequent
estimation of the relative efficiency of health systems,
with a high emphasis on a correct interpretation of
results.
In the work of Afonso & Aubyn [28], the DEA and the
Free Disposal Hull (FDH) approaches are used to
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estimate health and education efficiency in 24 OECD
countries. Luoma & Räty [29] give a critical view of the
study, pointing out the differences that may be created
in efficiency by using more appropriate forms of inputs
and outputs. They criticise an interpretation of the re-
sults of the input and output-oriented DEA model with
the VRS. Afonso & Aubyn [28] used one input and one
output to estimate efficiency. It may lead to an overesti-
mation of the results for eight OECD countries in the
output-oriented model. Luoma & Räty [29] performed
the same efficiency estimation process for each country.
However, the authors used revised data and excluded
the number of hospital beds from inputs as they do not
consider this indicator to be relevant input in the ana-
lysis. Similarly, the authors have considered the aggre-
gate indicator of the population’s health status and life
expectancy at birth. Suppose this indicator is used as an
output. In that case, they do not recommend including
in the analysis of health systems such inputs that only
refer to employees (e.g. number of physicians and
nurses) and technical aspects of institutions (e.g. the
number of beds). The main reason is that the indicator
of life expectancy at birth depends on a certain standard
of the population’s lifestyle and environmental and cul-
tural factors. Similar work has also been pursued by
Spinks & Hollingsworth [30] in which they discussed the
use of life expectancy at birth. The authors have consid-
ered a well-organised data collection, which takes into
account a quality of life (e.g. quality-adjusted life years
(QALYs) or health-adjusted life expectancy (HALE)).
Medeiros & Schwierz [20] only confirmed that efficiency
measurements might be performed in two ways. On the
one hand, by increasing health outcomes while main-
taining the current inputs (output-oriented models). On
the other, by reducing inputs at the current health out-
comes (input-oriented models).
Traditional DEA models are used in many works, and
these models provide a basis for measuring efficiency
based on inputs and outputs. These conventional DEA
models do not distinguish the efficiency of the various
components and/or health system. Woolf & Aron [31]
recommend, in the case of international comparisons of
the level of health systems, examining the efficiency be-
tween public health and medical care as components of
the whole health system. The evidence reviewed here
seems to suggest a pertinent role for deeper discussion.
Ozcan & Khushalani [32] investigated the efficiency of
public health and medical care systems on a sample of
34 OECD countries between 2000 and 2012. This study
differs from other studies in methodology, as the authors
use a new approach in the DEA analysis. The analysis is
based on the Dynamic Network Data Envelopment Ana-
lysis, where the authors used a non-oriented model with
CRS. This method is backed up by the evidence in
Kawaguchi et al. [33]. Ozcan & Khushalani [32] applied
the DNDEA model under the CRS. The authors focused
on a specific period in which some health reforms were
undertaken in OECD countries, with a common feature
of reducing costs and increasing value-added for
resources.
Most of the mentioned studies used traditional indica-
tors and traditional DEA models to analyse the efficiency
of the health sector as a whole (e.g. [2, 9, 11, 15, 17–20,
28, 34–38]). But the development in the last years
pointed to the fact that the overall efficiency of the
health sector is affected by the efficiency in different in-
terconnected areas (e.g. [32, 33, 39–41]). By analysing
the efficiency of the health sector as a whole, we are los-
ing information about activities within the individual
areas. Therefore, we decide to apply the network DEA
model, which help us to analyse the efficiency in individ-
ual areas of the health sector, taking into account links
between them. As mentioned by the expert panel on
Understanding Cross-National Health Differences
Among High-Income Countries, the health system en-
compasses the entire continuum between public health
and medical care area. The public health area represents
an area of healthcare where efficiency could be affected
by policymakers and experts in health sectors. For ex-
ample, they can take decisions in the legislative field,
which can help reduce alcohol or tobacco consumption,
increase vaccination rates against various dangerous dis-
eases, educate people about health issues, and this way
increase the overall life expectancy of the population.
The medical care area represents way how health ser-
vices are delivered to patients. By analysing this area of
the health system, we can find out if increasing invest-
ment into medical technologies or increasing the num-
ber of medical staff can help to improve the early
diagnosis of diseases and increase the number of hospital
discharges. It is essential to say that both areas are inter-
connected as the decision of policymakers and experts
can improve the efficiency not only within the health
care area but also within medical care area as it can in-
crease the number of vaccinated persons or a number of
cancer screening which help to improve the early diag-
nosis of diseases. Therefore, we decide to involve these
variables as linking between both areas, which can be
considered as contribution of our paper compared to
traditional DEA models.
Another shortcoming of previous studies is the appli-
cation of traditional DEA models for each year separ-
ately (e.g. [2, 9, 15, 17–20, 28, 34–37]). This unable us to
take into account activities which are transmitted be-
tween years. We could not consider that applying new
technologies or reducing alcohol and tobacco consump-
tion will positively affect life expectancy or infant mor-
tality in the same year. Therefore, we decide to apply a
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dynamic DEA model that allows us to apply carry-over
activities, which can positively affect the efficiency in dif-
ferent areas not in the same, but at a later time. With
the combination of both aspects, network and dynamic,
we can analyse the development of efficiency in different
areas of health sectors in OECD countries between the
years 2000, 2008, and 2016. This way, we can apply not
only standard inputs and outputs like alcohol and to-
bacco consumption, life expectancy, and employment
but also variables like immunisation, cancer screening,
and so on. Through the application of so-called link var-
iables, we can analyse if, for example, the increasing vac-
cination, increasing number of mammography
screenings based on the decision of policymakers and
experts in health sectors can improve the efficiency of
medical care and can have a positive effect on the life
expectancy of people leaving in the analysed countries.
We can also investigate if the decreasing infant mortality
or decreasing number of new cancer cases in the speci-
fied year resulted from a better condition in the health
system can have a positive effect on the efficiency in dif-
ferent areas, and this way on the overall efficiency of the
health sector in later time (in our sample eight years
later).
Compared to the previous studies (e.g. [2, 11, 17–20,
32, 36, 41, 42]), we decide to apply the input-oriented
DNDEA model as we want to find out how the country
could set its inputs effectively to reach given outputs.
We analyse the optimal reduction in alcohol and to-
bacco consumption in the public health area, leading to
given health-adjusted life expectancy in the specified
country. In the medical care area, we explore if the med-
ical technologies and employees are used effectively
compared to the provided services to patients. In calcu-
lating efficiency, we also consider links between both
areas and variables that can influence the efficiency with
time shift. As seen in the literature review, some authors
prefer to use the model under the constant returns to
scale assumption (e.g. [2, 10, 16, 17], [18, 32, 37], or
[41]), while others prefer variable returns to scale as-
sumption (e.g. [11, 15, 20, 34], or [36]). The advantage
of VRS is that we can eliminate size differences between
countries. But on the other hand, as mentioned by [10],
when variables are expressed in ratio form, we can apply
CRS model, as ratio form eliminates size effect. To verify
if there are significant differences between both assump-
tions in the case where ratios are used, we also apply
constant and variable returns to scale model, which also
can be considered as the contribution of the paper.
Taking these studies into account, we emphasise that
the health system consists of several subdivisions. There-
fore, this study aims to contribute to this growing area
of research by exploring a novel approach to assess
health efficiency. Considering all of this evidence, it
seems that applying a combination of dynamic and net-
work DEA analysis will serve as a continuous impulse
for future research. To fill a gap in the literature, we
have decided to apply our investigation not only to EU
countries but also to OECD countries, which offers us
the possibility of a more extensive comparison of a num-
ber of developed economies.
Methodology and data
The analysis focuses on assessing the efficiency of the
health systems of OECD countries over three periods:
2000, 2008 and 2016 using DEA analysis. The DEA, as
an analysis based on the application of mathematical
programming, was initially specified by Charnes et al.
[43] based on the work of Farell [44], and later devel-
oped by Banker et al. [45], Debreu [46], Shepherd [47]
and Afriat [48]. Since the first introduction of the DEA
method in 1978, the DEA has been widely used in many
investigational studies to model and evaluate operational
process performance, which does not require strict as-
sumptions as in other approaches, and is, therefore,
more flexible. This method is currently the subject of
further studies and applications within each model [49–
53]. The DEA analysis includes two basic conceptual
models: the CCR model, named after Charnes, Cooper
and Rhodes [43] and the BCC model, first introduced by
Banker, Charnes and Cooper [34]. The essence of the dif-
ference between these models results from an approach to
returns to scale. The CCR model assumes constant
returns to scale. The BCC model assumes a VRS. The in-
dividual weights for the evaluated decision-making units
(DMUs) in the DEA analysis are calculated to maximise
unit efficiency. A hypothetical (virtual) unit, characterised
as a weighted average of certain actual values of effective
units, may be determined for inefficient units. Such a unit
(the size of its inputs and outputs) serves as a model for a
real inefficient unit that produces fewer outputs or con-
sumes more inputs than its virtual unit. For the VRS
models, the requirement that α times the input must be
balanced by increasing the output by the same α times,
does not apply. Thus, the DMU may be efficient even if a
relative increase in outputs will be lower or higher than
the increase in inputs [54].
The Dynamic Network DEA represents the approach
taken by other authors to address the efficiency with a com-
bination of dynamic and network DEA analysis [55]. Stand-
ard DEA models do not analyse and contain no
information about the internal structure between the indi-
vidual DMUs examined. The efficiency score ranges be-
tween 0 and 1, where one indicates the unit is relatively
efficient, and a value < 1 indicates inefficiency. In the health
sector, the services are provided through several areas (de-
partments, or divisions) that contribute to the overall effi-
ciency of a larger unit (e.g. hospitals). In monitoring the
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efficiency of hospitals, the entire group includes, apart from
individual hospitals, other areas, such as nursing homes,
medical offices, outpatient surgical centres and diagnostic
centres. Traditional DEA models do not take into account
the internal structure of health organisations that act as
DMUs. Network DEA models are also reported by Färe &
Grosskopf [56] and later by Lewis & Sexton [39], who ap-
plied network DEA analysis between teams in the profes-
sional Major League Baseball in North America. Tone &
Tsutsui [40] expanded these core models by developing a
network model using slacks through the work of Tone [57],
which is a non-radial model for measuring efficiency in the
case of a disproportionate change in inputs and outputs.
The basic graphical concept of the internal structure of dy-
namic and network DEA models may be seen in Fig. 1.
Areas (divisions) of the health sector represent a subunit of
a healthcare facility, where each area may have its inputs
and outputs and may also be linked to other divisions. Dy-
namic network DEA models identify linking activities while
taking into account the internal heterogeneous structure of
DMUs.
The major advantage of applying the network DEA
analysis is the assumption that the overall efficiency of
the health system depends not only on political decisions
but also on healthcare provision. With this aim in mind,
in this paper, the efficiency is examined in two separate
areas of the health system, namely the efficiency in the
field of public health and the efficiency in medical care.
It is necessary to determine the so-called, linking activ-
ities’ variables between divisions within the network DEA
analysis. These variables represent activities that may
affect the efficiency of the second division, but in terms of
their applicability, they are regulated by the first division.
An advantage of the dynamic network DEA models is that
the efficiency measurement may be performed between
periods (time period t, t + 1, etc.). Since the DNDEA ana-
lysis combines network and dynamic DEA analysis, it is
necessary to include the carry-over variables, creating
intermediate links between variables from one to the other
period. These carry-over variables may affect efficiency in
the next period, either positively or negatively. Conse-
quently, good and bad (or positive and negative) carry-
over variables are considered. The mathematical formula-
tion of the dynamic network DNDEA analysis mentioned
below is based on Lewis & Sexton [39]; Tone & Tsutsui
[40], Kawaguchi et al. [33] and Ozcan & Khushalani [32].
DNDEA analysis can be adapted by considering
n DMUs (j = 1,…, n), which consist of K sub-divisions
(k = 1,…,K) during T time periods (t = 1,…,T). It may be
considered that mk will represent the number of inputs
and rk the number of outputs to sub-division k. Links be-
tween individual divisions (e.g., from division k to division
h) will be denoted as (k, h)l with the set of such links being
denoted as Lkh. The observed data are as follows:
fxtijk∈Rþgði ¼ 1;…;mk ; j ¼ 1;…; n; k ¼ 1; ::;K ; t ¼ 1;
…;TÞ is an input resource i to the unit DMUj of the
sub-division k in the period t. Analogically, fytrjk∈Rþgðr
¼ 1;…; rk ; j ¼ 1;…; n; k ¼ 1; ::;K ; t ¼ 1;…;TÞ repre-
sents an output product r from the unit DMUj for the
sub-division k in the period t. Also, undesirable outputs
are treated as inputs to the division k.
fztjðkhÞl∈Rþgð j ¼ 1;…; n; l ¼ 1;…; Lkh; t ¼ 1;…;TÞ rep-
resents the linking intermediate products of DMUj from
sub-division k to sub-division h in period t, where Lkh
represents the number of items in the links from k to h.
fzðt;tþ1Þjkl ∈Rþgð j ¼ 1;…; n; l ¼ 1;…; Lk ; k ¼ 1;…;K ; t
¼ 1;…;T−1Þ represents the carry-over of DMUj, sub-
division k from period t to the period t + 1, where Lk is
considered as the number of items in the carry-over
from sub-division k.
The decision-making unit DMUo (o = 1,…, n) ∈ P
t can
be specified as follows. The input and output constraints
can be expressed as follows:
Fig. 1 Dynamic and network DNDEA model concept. Source: Prepared by authors based on Ozcan [5]
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xtok ¼ Xtkλtk þ st−ko ∀k; ∀tð Þ
ytok ¼ Ytkλtk−stþko ∀k; ∀tð Þ





ko ≥0; ∀k; ∀tð Þ ð1Þ
where Xtk ¼ ðxt1k ;…; xtnkÞ∈RmknT a Ytk ¼ ðyt1k ;…; ytnkÞ∈
RrknT represent the input and output matrices and st−ko
and stþko represent, respectively, input and output slacks.
Different opinions were put forward regarding the link-
ing constraints. The “as input” link value case, the link-
ing activities are conducted as input to succeeding
division and excesses are accounted for in the input
inefficiency:
zto khð Þin ¼ Ztkhð Þinλtk
þ sto khð Þin khð Þin ¼ 1;…; linkinkð Þ ð2Þ
where stoðkhÞin∈R
LðkhÞin represents slacks and is non-
negative and linkink is the number of “as input” links
from sub-division k. In the “as output” link value case,
the linking activities are considered as an output from
the preceding division, and shortages are accounted for
in the output inefficiency:
zto khð Þout ¼ Ztkhð Þoutλtk−sto khð Þout khð Þout ¼ 1;…; linkoutkð Þ
ð3Þ
where stoðkhÞout∈R
LðkhÞout represents slacks and is non-
negative and linkoutk is the number of “as output” links
from a sub-division k. Subsequently, the carry-over vari-
ables may be classified into four categories, with a de-
tailed description in Table 1:
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As already mentioned, the dynamic network DEA ana-
lysis considers the internal heterogeneity of DMUs,
where the individual divisions are interconnected. Thus,
the model may be used to assess overall efficiency,
period efficiency, track changes in overall efficiency
across periods, and divisional efficiency to track changes
in efficiency across divisions between selected periods.
The objective function for the overall efficiency in the
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where, Wt(∀t) represents the weight to the period t and
wk(∀k) represents the weight to the sub-division k. These
Table 1 Definition of variables used in DNDEA model
Variable Definition
xtijk An input resource i to DMUj for the sub-division k at period t
ytrjk An output product r from DMUj for the sub-division k at period t
ztjðkhÞl A linking intermediate product of DMUj from sub-division k to sub-division h at period t
zðt;tþ1Þjkl
A carry−over of DMUj at the sub-division k from period t to period t + 1
st−iok A slack of the input i of DMUo for sub-division k at period t
stþrok A slack of the output r of DMUo for sub-division k at period t
stoðkhÞlα A slack of link(kh)l of DMUo at period t. α stands for free, " as input " and " as output"
sðt;tþ1Þoklα
A slack of carry-over variable kl from period t to period t + 1. α stands for free, good and bad




; and sðt;tþ1Þokl free
The slacks denoting, respectively, carry-over shortfall, carry-over excess and carry-over deviation
ngoodk; nbadk; nfreek The number of desirable (good), undesirable (bad) and free carry-over variables for each sub-division k.
Source: Prepared by authors
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weights satisfy the condition:
PT
t¼1




Wt ≥ 0 (∀t), wk ≥ 0 (∀k). They are supplied exogenously.
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Finally, period-divisional efficiency in the input-
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A ∀k; ∀tð Þ
ð8Þ
Further support for the output-oriented model is given
by Kawaguchi et al. [33] and Ozcan & Khushalani [32],
where detailed formulas are applied.
The definitions and descriptive statistics of the inputs
and outputs used in the analysis, are provided in Table 2.
The DNDEA model being used in this paper, as shown
in Fig. 2 considers a selected OECD country’s health sys-
tem as DMU. This health system is conceived as having
two sub-divisions – public health and medical care. Both
sub-divisions have the same weights, and both are im-
portant parts of the health system [31].
The inputs to the public health sub-division include to-
bacco and alcohol consumption as the standard inputs
used in previous studies e.g. [15, 17, 25], or [32]. The out-
put for the public health sector is considered the health-
adjusted life expectancy. Most studies in the field of meas-
uring efficiency in health work with life expectancy (e.g.
[1, 17, 18, 20, 32]). To overcome the shortcomings of pre-
vious studies outlined above, we propose using the health-
adjusted life expectancy in the public health sub-division
as the output. Using the HALE indicator better demon-
strates and captures the quality of life in a country, as this
indicator shows how many years a person is expected to
live in good health [58–60]. Preventive services, such as
immunisation, breast cancer screening, and cervical can-
cer screening, affect the quality of medical care services,
but these are regulated at the level of the national health-
care division. Therefore we decide to use these variables
not as inputs in medical care, but we use these preventive
services as links between divisions. We can consider them
as good links to the medical care area as they reduce the
disease burden on the medical care area.
The input-oriented DNDEA model will be considered.
It may minimise the inputs to achieve given results in
the healthcare area, i.e. how a country should set its in-
put indicators effectively to reach given outputs, namely
the health-adjusted life expectancy. Since it is assumed
that the adjustment of inputs cannot significantly in-
crease this output at one time, but its level is given, the
input-oriented models are used. There will be examined
what should be the optimum level of public health input
that corresponds to HALE. Similarly, there is involved a
carry-over variable in the field of public health. In this
case, such a variable is an indicator of infant mortality.
The carry-over variable may affect the efficiency of a
given division positively or negatively, but most likely
not immediately in a given period. Its impact on the effi-
ciency of public health will be reflected only after some
time delay. The infant mortality indicator has an adverse
effect on the level of healthcare in a given country, while
rising values of this indicator have a negative impact on
the overall efficiency of healthcare in a country.
The inputs to the medical care area include the number
of persons working in the health care sector and the num-
ber of computer tomography devices in the country. These
inputs represent capital, technology and labour and are
commonly used in efficiency evaluation (e.g. [11, 15–18, 20,
28, 32–38, 41, 42]). Outputs from the medical care area
represent the number of hospital discharges and consulta-
tions in a year. These are commonly used outputs in the
evaluation efficiency of the medical care system (e.g. [2, 5,
9, 32, 35, 36], or [41, 42]). One of the advantages of the
DNDEA model, which can be considered a contribution of
the paper, is that we can consider so-called carry-over activ-
ities affecting the efficiency with time shift. In the medical
care area, we include as carry-over the number of new can-
cer cases. As cancer is considered one of the most serious
diseases of the last decade, which significantly burdens the
health system, we decided to choose it for our analysis. The
increasing number of new cancer cases represents an in-
creased need to purchase new equipment and the increased
number of medical staff in the future. Therefore, we con-
sider it as undesirable (bad) carry-over of medical care area
from one period to another.
The health-adjusted life expectancy (HALE) was col-
lected from the Global Health Observatory database,
which is World Health Organization’s data repository
for health-related statistics for all member states. The
HALE can be found under the “Indicator Groups” sec-
tion in the sub-section “Healthy life expectancy”. All
other indicators were collected from the online statistical
platform of the OECD’s statistical databases. The Alco-
hol consumption and Tobacco consumption are avail-
able in the section “Health” and in the sub-section
Gavurova et al. Health Economics Review           (2021) 11:40 Page 8 of 25
“Non-Medical Determinants of Health”. Immunisation,
Breast cancer screening and Cervical cancer screening
are available in the section “Health” in the sub-section
“Health Care Utilisation” in the dimensions “Immunisa-
tion” or “Screening”, respectively. Infant mortality and
Incidence of cancer are available in the section “Health”
in the sub-section “Health Status” in the dimensions
“Maternal and infant mortality” or “Cancer”, respect-
ively. Medical technology refers to the number of com-
puter tomography devices per one million inhabitants,
and it is available in the section “Health” in the sub-
section “Health Care Resources”. Employment in health-
care is available in the section “Health” in “Health Care
Resources” in the dimension “Total health and social
employment”. Inpatient discharges are available in the
section “Health” in the sub-section “Health Care Utilisa-
tion” in the dimension “Hospital discharges by diagnos-
tic categories”. Consultations are available in the section
“Health” in the sub-section “Health Care Utilisation” and
refer to the average number of consultations per phys-
ician per capita. All data were collected for 2000, 2008
and 2016 (as the last available data).
Results
DNDEA analysis was conducted using DEA-Solver-Pro
Version 13.0. An input-oriented DNDEA model was per-
formed. The first goal in the analytical part was to find a
suitable way to adjust the inputs to achieve efficiency.
Table 2 Classification of the indicators used and their descriptive statistical characteristics
2000 2008 2016
Indicator Definition Avg / Min / Max Avg / Min / Max Avg / Min / Max
Public health sub-division
Inputs
Alcohol consumption Annual alcohol consumption in litres per capita aged
15 years and older
9.5 / 1.5 / 14.2 9.7 / 1.5 / 14.2 8.9 / 1.3 / 13.2
Tobacco
consumption
Annual consumption in grams of tobacco products
(e.g. cigarettes, cigars, ...) per capita aged 15 years and
over




The average number of years that a person is expected
to live in good health by taking into account years lived
in less than full health due to disease and/or injury
68.0 / 60.6 / 72.5 70.1 / 64.4 / 73.8 71.1 / 66.0 / 74.8
Links to medical care sub-division
Immunisation Percentage of children under 1 year of age who were
vaccinated against diphtheria, tetanus and whooping
cough in that year
92.9 / 78.0 / 99.0 95.2 / 80.0 / 99.0 95.4 / 87.0 / 99.0
Breast cancer
screening
Number of women aged 50–69 years who have
undergone mammography in the last 2 years / number
of women aged 50–69 years who answered survey questions
51.7 / 0.9 / 88.1 57.6 / 9.6 / 89.7 60.2 / 18.1 / 90.4
Cervical cancer
screening
Number of women aged 20–69 years examined in the
last 3 years / number of women aged 20–69 years who
answered survey questions
56.1 / 6.3 / 90.6 59.9 / 14.9 / 85.9 61.9 / 18.2 / 86.6
Carry-over
Infant mortality Number of deaths of children under 1 year of age,
calculated per 1000 births





Number of computer tomography devices per
1000,000 inhabitants
16.1 / 2.5 / 92.6 21.2 / 4.0 / 97.0 25.9 / 6.1 / 107.2
Employment in
healthcare
Total number of doctors and nurses in health care
calculated per 1000 inhabitants




The average number of hospital discharges per
100,000 population for all diagnostic diseases
15,982.3 / 4016.6 /
25,933.3
16,105.1 / 4603.5 /
28,114.5
15,816.7 / 4617.2 /
25,685.9
Consultations Average number of consultations per physician per
capita




New cancer cases recalculated to 100,000 inhabitants 277.9 / 91.0 / 420.0 259.9 / 128.4 / 321.1 269.3 / 131.5 / 338.1
Source: Prepared by authors
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Ozcan & Khushalani [32] present options for adjusting
inputs and outputs in this model. The focus is put on
adjusting and re-evaluating the inputs at each level of
HALE. The models’ results were interpreted using this
indicator because the efficiency results are similar to
those obtained when using the life expectancy at birth.
The results of the DNDEA models with the assumption
of constant returns to scale and variable returns to scale
in 2000, 2008 and 2016 in each sub-division are shown
in Table 3 and Table 4.
The analysis results for the public health sub-division,
medical care sub-division and overall health system for
OECD countries under the assumption of CRS in Table
3 indicate that the average overall efficiency was 0.8801
in 2000. Twenty-one countries have achieved a higher
efficiency compared to the average in 2000. On the other
hand, fifteen countries have achieved a lower efficiency
compared to the average in 2000. In 2008 the average
overall efficiency was 0.8807, where nineteens countries
have achieved a higher efficiency than the average in
2008, and seventeen countries have achieved a lower ef-
ficiency than the average in 2008. In 2016 the average
overall efficiency was 0.8472, where twenty-one coun-
tries have achieved a higher efficiency than the average
in 2016, and fifteen countries have achieved a lower effi-
ciency than the average in 2016. According to the
achieved score, we can mark as efficient in all three
years: Austria (AUT), Finland (FIN), Chile (CHL), Japan
(JPN), Mexico (MEX), and Turkey (TUR). According to
the literature, the high-efficiency scores in these coun-
tries could be explained by healthcare reforms taken
during the years 2000–2012 [33]. When we look at the
efficiency scores of sub-divisions, we can see that the
average efficiency of the public health sub-division was
0.8836 in 2000, 0.8723 in 2008 and 0.8051 in 2016. In
2016 sixteen countries achieved a higher efficiency com-
pared to the average in the public health sub-division. In
the medical care sub-division, the average was 0.8766 in
2000, 0.8891 in 2008 and 0.8893 in 2016. When we com-
pare the level of public health sub-division and medical
care sub-division efficiency score, we can see that the ef-
ficiency of the public health sub-division in 2016 was
higher than medical care sub-division only in Australia
(AUS), Denmark (DNK), Iceland (ISL), Norway (NOR)
and United States (USA). In the case of Belgium (BEL),
Canada (CAN), Czech Republic (CZE), Estonia (EST),
France (FRA), Germany (DUE), Hungary (HUN), Ireland
(IRL), Italy (ITA), Latvia (LVA), Lithuania (LTU), New
Zealand (NZL), Poland (POL), Portugal (PRT), Korea
(KOR), Slovak Republic (SVK), Spain (ESP), Switzerland
(CHE), and United Kingdom (GBR), the medical care
sub-division was more efficient. Comparing the results,
we can say that the countries tend to be more efficient
within the medical care sub-division. Both divisions were
efficient in the case of Austria (AUT), Finland (FIN),
Greece (GRC), Chile (CHL), Israel (ISR), Japan (JPN),
Luxembourg (LUX), Mexico (MEX), Netherland (NDL),
Slovenia (SVN), Sweden (SWE), and Turkey (TUR).
The results of the analysis for the public health sub-
division, medical care sub-division and overall health
system for OECD countries under the assumption of
variable returns to scale in Table 4 indicate that the
average overall efficiency was 0.9320 in 2000 and eleven
countries have achieved a lower efficiency compared to
the average in 2000. In 2008 the average overall effi-
ciency was 0.9504, where nine countries have achieved a
lower efficiency compared to the average in 2008. In
2016 the average overall efficiency was 0.9371, where
eleven countries have achieved a lower efficiency com-
pared to the average in 2016. According to the achieved
score, we can mark as inefficient in all three years:
Australia (AUS), Belgium (BEL), Denmark (DNK),
Estonia (EST), Iceland (ISL), Ireland (IRL), Italy (ITA),
New Zealand (NZL), Norway (NOR) and Switzerland
(CHE). When we look at the efficiencies of sub-
divisions, we can see that the average efficiency of the
Fig. 2 DNDEA model. Source: Prepared by authors based on Ozcan [5] and Ozcan & Khushalani [32]
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public health sub-division was 0.9334 in 2000, 0.9598 in
2008 and 0.9382 in 2016. In the medical care sub-
division, the average was 0.9305 in 2000, 0.9410 in 2008
and 0.9360 in 2016. When we compare the level of pub-
lic health sub-division and medical care sub-division effi-
ciency score, we can see that the efficiency of the public
health sub-division in 2016 was higher than medical care
sub-division only in Australia (AUS), Belgium (BEL),
Denmark (DNK), Iceland (ISL), Italy (ITA), Norway
(NOR) and Switzerland (CHE). In the case of the Czech
Republic (CZE), Estonia (EST), Ireland (IRL), Lithuania
(LTU), New Zealand (NZL), and United Kingdom
Table 3 Efficiency results - DNDEA model with CRS in OECD countries
DMU Overall efficiency score The efficiency of public health sub-division The efficiency of medical care sub-division
2000 2008 2016 2000 2008 2016 2000 2008 2016
AUS 0.715 0.663 0.5879 0.8259 0.7757 0.6444 0.6042 0.5503 0.5315
AUT 1 1 1 1 1 1 1 1 1
BEL 0.703 0.7534 0.6141 0.7447 0.7498 0.5583 0.6613 0.757 0.6698
CAN 0.7876 0.8468 0.7836 0.8099 0.7703 0.7005 0.7653 0.9234 0.8667
CZE 1 0.9233 0.8965 1 0.8465 0.7931 1 1 1
DNK 0.6198 0.6214 0.6286 0.5818 0.642 0.6503 0.6577 0.6008 0.6068
EST 0.9362 0.7669 0.7527 0.8723 0.6247 0.65 1 0.909 0.8554
FIN 1 1 1 1 1 1 1 1 1
FRA 1 0.835 0.7032 1 0.6868 0.4872 1 0.9833 0.9191
DEU 0.6913 0.7918 0.7076 0.6175 0.8073 0.4996 0.765 0.7763 0.9157
GRC 0.9188 1 1 0.8376 1 1 1 1 1
HUN 0.8504 0.8307 0.9111 0.7008 0.6615 0.8223 1 1 1
CHL 1 1 1 1 1 1 1 1 1
ISL 0.8052 0.7758 0.7874 1 1 1 0.6105 0.5516 0.5748
IRL 0.6403 0.6801 0.6788 0.5994 0.661 0.6131 0.6813 0.6992 0.7444
ISR 0.9547 1 1 1 1 1 0.9094 1 1
ITA 0.7335 0.7838 0.6763 0.8119 0.8784 0.6671 0.655 0.6893 0.6855
JPN 1 1 1 1 1 1 1 1 1
LVA 1 0.8492 0.7935 1 0.7512 0.7351 1 0.9471 0.8519
LTU 1 1 0.8573 1 1 0.7146 1 1 1
LUX 0.8147 0.86 1 1 1 1 0.6294 0.7201 1
MEX 1 1 1 1 1 1 1 1 1
NLD 0.8111 0.884 1 0.8022 0.8304 1 0.82 0.9376 1
NZL 0.6679 0.7532 0.7144 0.6141 0.7252 0.6669 0.7217 0.7811 0.7619
NOR 0.9063 0.8456 0.8333 1 0.9284 1 0.8126 0.7629 0.6666
POL 0.9209 0.8849 0.7754 0.8419 0.7698 0.5508 1 1 1
PRT 0.9943 1 0.8877 0.9887 1 0.7755 1 1 1
KOR 1 1 0.8715 1 1 0.7429 1 1 1
SVK 1 1 0.8529 1 1 0.7071 1 1 0.9987
SVN 0.8784 1 1 0.8245 1 1 0.9322 1 1
ESP 0.8546 0.8538 0.8735 0.7091 0.7075 0.7469 1 1 1
SWE 0.958 1 1 1 1 1 0.916 1 1
CHE 0.6359 0.6766 0.5715 0.6786 0.7321 0.5512 0.5933 0.621 0.5917
TUR 1 1 1 1 1 1 1 1 1
GBR 0.9747 0.9274 0.8528 0.9493 0.8547 0.7056 1 1 1
USA 0.911 0.8995 0.8872 1 1 1 0.8221 0.7989 0.7744
Average 0.8801 0.8807 0.8472 0.8836 0.8723 0.8051 0.8766 0.8891 0.8893
Source: Prepared by authors
Gavurova et al. Health Economics Review           (2021) 11:40 Page 11 of 25
(GBR), the medical care sub-division was more efficient.
In other countries, both divisions were efficient in 2016.
A closer examination of the results reveals some inter-
esting findings of countries differences. In Table 5, we
analyse Austria, Finland, Greece, Chile, Japan, Mexico
and Turkey. These countries have reached higher than
average efficiency scores in all three years examined. By
further researching, we have tried to find out what these
countries can have in common. These countries experi-
enced several reforms in the reporting period, which had
a significant impact on health care and the health sys-
tem. Table 5 shows the level of individual indicators
Table 4 Efficiency results - DNDEA model with VRS in OECD countries
DMU Overall efficiency score The efficiency of public health sub-division The efficiency of medical care sub-division
2000 20,008 2016 2000 2008 2016 2000 2008 2016
AUS 0.7178 0.6642 0.6429 0.8427 0.7562 0.7327 0.5929 0.5721 0.5531
AUT 1 1 1 1 1 1 1 1 1
BEL 0.7453 0.9301 0.7541 0.7673 1 0.788 0.7234 0.8601 0.7203
CAN 1 1 1 1 1 1 1 1 1
CZE 1 1 0.9002 1 1 0.8003 1 1 1
DNK 0.6655 0.6295 0.6551 0.6161 0.6604 0.6839 0.7148 0.5986 0.6262
EST 0.9373 0.7745 0.8453 0.8745 0.6328 0.794 1 0.9162 0.8965
FIN 1 1 1 1 1 1 1 1 1
FRA 1 1 1 1 1 1 1 1 1
DEU 0.7355 1 1 0.7142 1 1 0.7569 1 1
GRC 0.9229 1 1 0.8459 1 1 1 1 1
HUN 1 1 1 1 1 1 1 1 1
CHL 1 1 1 1 1 1 1 1 1
ISL 0.867 0.7916 0.8221 1 1 1 0.734 0.5831 0.6442
IRL 0.7344 0.8987 0.8783 0.6211 0.7974 0.7566 0.8476 1 1
ISR 1 1 1 1 1 1 1 1 1
ITA 0.7372 0.8175 0.7339 0.8111 0.9381 0.7523 0.6632 0.697 0.7155
JPN 1 1 1 1 1 1 1 1 1
LVA 1 1 1 1 1 1 1 1 1
LTU 1 1 0.8578 1 1 0.7156 1 1 1
LUX 1 1 1 1 1 1 1 1 1
MEX 1 1 1 1 1 1 1 1 1
NLD 1 1 1 1 1 1 1 1 1
NZL 0.697 0.7754 0.7781 0.6726 0.768 0.7527 0.7215 0.7829 0.8035
NOR 0.9071 0.9328 0.8682 1 1 1 0.8142 0.8655 0.7364
POL 1 1 1 1 1 1 1 1 1
PRT 1 1 1 1 1 1 1 1 1
KOR 1 1 1 1 1 1 1 1 1
SVK 1 1 1 1 1 1 1 1 1
SVN 0.8853 1 1 0.8371 1 1 0.9335 1 1
ESP 1 1 1 1 1 1 1 1 1
SWE 1 1 1 1 1 1 1 1 1
CHE 0.9985 0.9999 0.9999 1 1 1 0.997 0.9999 0.9998
TUR 1 1 1 1 1 1 1 1 1
GBR 1 1 1 1 1 0.9999 1 1 1
USA 1 1 1 1 1 1 1 1 1
Average 0.9320 0.9504 0.9371 0.9334 0.9598 0.9382 0.9305 0.9410 0.9360
Source: Prepared by authors
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Table 5 Comparison of countries with above average efficiency (CRS model)
Indicator Year AUT FIN GRC CHL JPN MEX TUR OECD Average
Alcohol consumption 2000 13.20 8.60 9.20 6.20 8.60 5.00 1.50 9.48
2008 12.00 10.30 9.50 7.40 7.50 4.00 1.50 9.70
2016 11.40 8.40 6.50 7.90 7.20 4.40 1.30 8.91
00–16 −1.80 −0.20 −2.70 1.70 −1.40 −0.60 −0.20 − 0.57
Tobacco consumption 2000 24.30 23.40 35.00 33.00 27.00 12.40 32.10 25.74
2008 23.20 20.40 39.70 29.80 21.80 10.80 27.40 22.18
2016 24.30 15.00 27.30 24.50 18.30 7.60 26.50 18.83
00–16 0.00 −8.40 −7.70 −8.50 −8.70 −4.80 −5.60 −6.92
HALE 2000 69.50 68.50 69.60 67.80 72.50 65.60 60.60 67.98
2008 71.40 70.40 71.50 68.90 73.80 66.50 64.40 70.11
2016 72.40 71.70 72.00 69.70 74.80 67.70 66.00 71.10
00–16 2.90 3.20 2.40 1.90 2.30 2.10 5.40 3.12
Immunisation 2000 81.00 99.00 89.00 91.00 85.00 97.00 85.00 92.89
2008 83.00 99.00 99.00 95.00 98.00 96.00 96.00 95.22
2016 87.00 92.00 99.00 95.00 99.00 97.00 98.00 95.42
00–16 6.00 −7.00 10.00 4.00 14.00 0.00 13.00 2.53
Breast cancer screening 2000 80.20 87.40 49.60 16.40 23.80 0.90 30.20 51.67
2008 80.20 84.90 53.80 19.30 23.80 9.60 24.70 57.60
2016 72.70 82.20 59.60 36.90 41.00 18.10 33.20 60.20
00–16 −7.50 −5.20 10.00 20.50 17.20 17.20 3.00 8.53
Screening cervical cancer 2000 81.50 70.30 59.40 64.50 22.60 6.30 36.80 56.14
2008 82.30 69.00 70.00 68.00 24.50 19.00 24.00 59.87
2016 86.60 69.80 75.50 55.90 42.40 18.20 47.80 61.91
00–16 5.10 −0.50 16.10 −8.60 19.80 11.90 11.00 5.77
Infant mortality 2000 4.80 3.80 5.90 8.90 3.20 20.80 28.40 6.77
2008 3.70 2.60 2.70 7.80 2.60 15.10 15.70 4.63
2016 3.10 1.90 4.20 6.90 2.00 12.10 10.00 3.87
00–16 −1.70 −1.90 −1.70 −2.00 −1.20 −8.70 −18.40 −2.90
Medical technology 2000 26.09 13.52 25.48 10.20 92.62 2.45 4.89 16.11
2008 29.68 16.45 31.05 10.20 96.97 4.01 10.68 21.21
2016 29.07 24.20 36.66 14.76 107.17 6.12 14.53 25.94
00–16 2.98 10.68 11.18 4.56 14.55 3.67 9.64 9.83
Employment 2000 11.01 13.21 7.12 2.34 10.36 3.78 2.36 10.01
2008 12.13 15.86 9.39 2.70 11.73 4.24 3.00 11.30
2016 13.12 17.62 9.84 5.02 13.77 5.25 3.76 12.49
00–16 2.11 4.41 2.72 2.68 3.41 1.47 1.40 2.47
Hospital discharges 2000 25,933.30 21,444.70 16,242.50 10,057.90 10,326.50 4016.60 7711.90 15,982.29
2008 28,114.50 18,405.90 20,050.20 9639.60 11,161.70 4603.50 13,629.90 16,105.10
2016 25,310.00 16,555.40 19,645.60 9000.00 12,638.80 4617.20 16,785.70 15,816.70
00–16 − 623.30 − 4889.30 3403.10 −1057.90 2312.30 600.60 9073.80 − 165.59
Consultations 2000 6.70 4.30 4.30 2.40 14.40 2.50 2.80 6.17
2008 6.90 4.30 4.00 3.00 13.20 2.80 6.70 6.52
2016 6.60 4.30 4.00 3.50 12.80 2.90 8.60 6.85
00–16 −0.10 0.00 −0.30 1.10 −1.60 0.40 5.80 0.68
Gavurova et al. Health Economics Review           (2021) 11:40 Page 13 of 25
used in our models, health expenditures in US$ per
capita and as % of GDP per capita all compared to the
OECD average.
Austria’s health system is based on social insurance
scheme. The federal government, social health insurance
funds, the states (Länder) and municipalities all are re-
sponsible to some extent for the organisation of public
and medical care, and all contribute to the health budget
framework [61]. The fragmentation of the organisation
of Austria’s health system has been adjusted through the
new “target-based governance” system started in 2013
within a view of further reforms in the pipeline. Among
the countries with the highest efficiency scores, health
spending was the highest and well above the OECD
average. Austria spent 2703.63 US$ per capita in 2000,
and health expenditures almost doubled to 5273.24 US$
per capita by 2016, representing 10.4% of GDP (8.9%
OECD average). In 2016 HALE was 72.4 years, 2.9 years
higher than in 2000 and 1.3 years above the OECD aver-
age. The gaps remain in vaccination coverage (immun-
isation level) compared to the OECD average during the
years. As is stated by OECD [61], behavioural risk fac-
tors and the ageing population will be the challenge of
Austria’s health system. Despite a reduction since 2000
the alcohol consumption remains above the OECD aver-
age. Tobacco consumption among 15-year-olds remains
above the OECD average, and overweight, obesity, and
unhealthy diets represent serious health concerns [62].
The fragmented structure of the health system generally
tends to a good level of health, but it seems more costly
compared to other OECD countries, which allows a
more detailed examination of efficiency at the regional
level.
Finland’s health system has implemented several re-
forms in recent years, further described by Keskimäki
et al. [63]. Health spending is less than in Austria but
still above the OECD average. The health system faces
rapid technological change, an ageing population and
behavioural health risks. Relatively high-efficiency scores
are complemented by the low levels of health spending.
In 2001, Finland’s government published a new health
strategy, “Government Resolution on the Health 2015
public health programme” [64]. In 2016 HALE was 71.7
years, 3.2 years higher than in 2000, and 0.6 above the
OECD average, reflecting the positive impacts of govern-
ment policies and interventions of implemented reforms.
The progress can also be seen in risky factors as alcohol
consumption and tobacco consumption. Both indicators
have reached levels below the OECD average during the
years. As stated by OECD [65], obesity rates have shown
modest results and can be considered as one of the main
public health concerns in the coming years. Finland has
reached significant improvement in infant mortality
since 2000. Health expenditure has more than doubled
since 2000, while the share of expenditure expressed as
% of GDP has also increased by more than 2.6%, which
can be assessed positively in the health system’s per-
formance. OECD [65] refers to the large social inequal-
ities in life expectancy not only by gender but also by
socioeconomic status and the level of education.
Greece scored best among the analysed group of coun-
tries in the Malmquist results (see Table 7). Efficiency
results also indicate a good level of health care and the
health status of the population over the reporting period.
We would like to point out that Greece has the biggest
efficiency improvement between 2000 and 2016, that is,
Table 5 Comparison of countries with above average efficiency (CRS model) (Continued)
Indicator Year AUT FIN GRC CHL JPN MEX TUR OECD Average
Cancer 2000 237.00 247.00 162.00 176.70 201.10 91.00 144.80 277.87
2008 250.60 250.10 162.00 176.70 201.10 128.40 144.80 259.93
2016 254.10 256.80 163.00 175.70 217.10 131.50 205.10 269.26
00–16 17.10 9.80 1.00 −1.00 16.00 40.50 60.30 −8.61
Health expenditure * 2000 2703.628 1828.671 1413.592 667.5 1917.971 484.387 425.6 1760.69
2008 4018.27 3231.159 2895.361 1113.972 2852.863 846.849 836.811 2962.61
2016 5273.243 4117.913 2262.788 1892.592 4585.388 1020.301 1092.466 3867.04
00–16 2569.62 2289.24 849.20 1225.09 2667.42 535.91 666.87 2106.35
Health expenditure % of GDP ** 2000 9.20 6.84 7.24 7.04 7.15 4.45 4.62 7.16
2008 9.73 8.08 9.38 6.74 8.20 5.70 5.26 8.16
2016 10.44 9.49 8.45 8.19 10.84 5.47 4.31 8.88
00–16 1.23 2.66 1.21 1.15 3.69 1.02 −0.31 1.72
* Curent expenditure on health, per capita, US$ purchasing power parities (current prices)
** Current expenditure on health, % of gross domestic product
Source: prepared by authors
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during the period when the country was the most ad-
versely affected by the Great Recession of all OECD
countries. Among the OECD countries, Greece’s health
system in recent years has undergone a major transform-
ation. Health reforms were linked to the economic crisis
and subsequently to the series of Economic Adjustment
Programmes since 2010. The huge step forward was es-
tablishing the National Organisation for the Provision of
Health Services to foster unified health insurance [66].
The important role also plays a new health technology
assessment agency. Greece has reached the highest
wasteful spending on pharmaceuticals in 2009. The gov-
ernment has established legislation for more than two
million people who lost health insurance during the pre-
vious economic crisis. During the period, a rapid de-
crease in health spending can be observed. The current
levels of health expenditures stabilised just before 2016.
In 2016, Greece spent 2262.79 US$ per capita, well
below the OECD average, representing 8.5% of GDP
(8.9% OECD average). Greece has relatively high and en-
couraging levels of immunisation, as well as HALE at 72
years in 2016, representing an improvement from 69.6
years in 2000. The policy agreements and financial sup-
port from the European Structural and Investment
Funds and the European Regional Development Fund
have moved the health system to a higher level. In the
area of technological change, this is visible in the in-
crease in the number of CT devices per one million in-
habitants, which reached 36.7, well above the OECD
average in 2016 (25.9). According to Economou et al.
[67], alcohol consumption,tobacco consumption, and
mainly socio-economic disproportional gaps, will play an
important health risk factor and continue challenging
Greece’s health system.
Over the past years, there were significant improve-
ments in Chilean’s health system and public health
architecture. To improves the Chileans’ health status
government has introduced the framework of policies
toward significant change. The National Health Fund –
Fondo Nacinal de Salud, known as FONASA, is respon-
sible for health coverage. In 2005, Chile implemented a
guaranteed package with access to the treatments,
known as AUGE (see Auraaen et al. [68]; Barasa et al.
[69]). The improvement in the health system is also as-
sociated with the Ricardo Soto Law introduced in 2015,
re-examined in 2017. Despite many successes due to re-
forms, the health system is still below indicators that are
at least similar to the OECD average. Health expendi-
tures in 2016 was 1892.59 US$, well below the OECD
average, representing more than 8.1% of GDP. In 2016,
infant mortality was relatively high compared to the
OECD average. According to OECD [70], Chile faces a
number of natural hazards, earthquakes, tsunamis, wild-
fires and landslides, which represent high public health
risks. Tuxedo rates are still very high compared to the
OECD average. Alcohol consumption is below the
OECD average but rising since 2000. Based on OECD
[70], Chilean’s health system recorded several significant
improvements but addressing obesity and overweight
need to be a priority in the coming future. More can also
be done in terms of cancer screening. Chile has low
screening rates for cervical and breast cancers compared
to the OECD average.
A more detailed look at the individual indicators
shows that Japan has the longest living and seems to
have the healthiest population at all. Healthy adjusted
life expectancy at birth was 74.8 years in 2016, 3.7 years
higher than the OECD average. The alcohol and tobacco
consumption rates are also below the OECD average
[71]. Based on OECD [72] Japan’s obesity and the over-
weight rate are the lowest in the OECD. But on the
other hand, the ageing population seems to be a chal-
lenge for Japan’s health system in the next years. Health
Japan 21, focused on primary prevention [72], is the win-
ner of success in the health sector. In 2003 legal act was
implemented, started developing the strategy. Health
Japan 21 strategy has already two terms (first started
from 2000 to 2013, and second started from 2013 to
2022). The second term brings a new framework con-
sisting of 53 targets. Health Japan 21 is considered to be
a comprehensive framework implemented at the local
level and aimed at promoting healthy lifestyles. Japan,
also like Chile, faces a number of natural hazards as
earthquakes, floods, and tsunamis, which represent high
public health risks. The level of immunisation is very
high, and the infant mortality rate is positively below the
OECD average.
Investment in health care in Mexico has increased in
recent years [73]. Health expenditure grew from 4.5% of
GDP in 2000 to 5.5% of GDP in 2016. The fundamental
part of the health system in Mexico is the cluster of sub-
systems [74]. Individuals affiliation is determined by
their job. There are fragmented packages and different
sets of providers belonging on the one hand to Seguro
Popular or on the other to the Institute for Social Secur-
ity and Services for State Employees [75]. As is stated by
OECD [73], the health system should change the pos-
ition narrowing to high-quality care provision. Mexico
has reached the improvement in HALE, from 65.6 years
in 2000 to 67.7 in 2016. Since 2000 the rapid decrease in
infant mortality is evident but remains well above the
OECD average. The immunisation level in Mexico is
above the OECD average. The OECD [73] emphasise, in
the face of health system challenges, several reforms to
Mexico’s health system.
Several health reforms were implemented by the Turk-
ish government in the last years [76]. Health Transform-
ation Programme began in 2003 and was complemented
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by significant health investments. Since 2003 the access
to health care has spread rapidly. Among other things,
these reforms led to an increase in health expenditure
from 2000 to 2016. In 2016, they were at 1092.47 US$,
still well below the OECD average. Health expenditures
in terms of % of GDP went from 4.6% in 2000 to 4.3% in
2016. HALE, Immunisation and Infant mortality rates
have improved impressively since 2000. Despite the suc-
cess, health indicators are still below the OECD average,
and there is still room for improvement. The OECD [77]
proposes to continue the set the trend and focus on en-
suring the quality of health services.
On the other hand, between the countries with the
lowest efficiency (Table 3), we can see Denmark in 2000.
The reason was the lowest efficiency within the public
health sub-division, where a relatively high level of alco-
hol and tobacco consumption could be seen compared
to the level of HALE. According to the OECD [78] re-
port, harmful alcohol use is associated with numerous
adverse health outcomes, early retirement, and social
consequences. It also contributes to premature death,
morbidity and disability. But in the last years, the posi-
tive development in this area could be seen. Alcohol
consumption in Denmark fell by 27% between 2000 and
2013, and this way, the efficiency slightly increased. The
Danish government prepared national law and prohib-
ited the sale of alcohol to anyone under the age of 16.
The Danish Health Authority’s alcohol control activities
focus mainly on preventing alcohol abuse in specific set-
tings through several projects, provides evidence-based
recommendations concerning alcohol prevention to
municipalities.
Another country with the lowest efficiency is Australia
in 2016, where the reason is the lowest efficiency within
the medical care sub-division. As the source of ineffi-
ciency, we can consider the inefficient usage of technolo-
gies and employees compared to the outputs. Australia
is a country with a well-developed system and medical
infrastructure. But when we compare the level of dis-
charges and consultations, we can see that other coun-
tries can provide a similar level of services with a lower
level of technologies and employees. Therefore, in the
case of this country, the space for increase of effective
usage of technologies and employees could be seen. An-
other fact is that despite the high level of technology, the
increasing tendency of new cancer cases could be seen.
According to the report of OECD [79], it is necessary to
implement a uniform electronic health record system to
improve the transfer of information between health care
services. It is also important to create a primary health
care eco-system around general practitioners and pro-
mote their role as care coordinators for patients with
chronic diseases. They also suggest providing financial
incentives for doctors to provide integrated care,
improve the quality and outcomes of health care, and
engage more in preventive health care.
However, we consider it important to highlight that in
our analysis, we did not only remain with the outcomes
of the CRS or VRS models, but we carried out a deeper
comparison of countries also in the context of the exclu-
sion of outlier observations, which can be considered as
different from previous studies. The sensitivity of the
DEA analysis to individual data also confirms the im-
portance of additional verification of the results, exclud-
ing outlier observations, since AUT, GRC, CHL, JPN,
MEX and TUR were highly represented by outliers.
The DEA models are sensitive to extreme values (out-
liers) for inputs and outputs [54]. Therefore, an add-
itional analysis by using box-plot charts was performed.
The results of the DNDEA model with VRS are pre-
sented in Table 6, taking into account the outliers of in-
dividual inputs and outputs in the selected countries.
Consequently, the number of OECD countries was re-
duced. To consider the deletion of the countries with ex-
treme values, the sample was reduced to 23 OECD
countries. The results show that the average efficiency
increased by approximately 4% after the outliers were
excluded. In all countries, an increase in efficiency after
eliminating outliers may be observed, and in either case,
there was no decrease in efficiency. The most significant
efficiency growth was found in Australia (AUS), Italy
(ITA) and New Zealand (NZL). It may be assumed that
the consideration of countries with extremely low and/
or extremely high values of inputs and outputs influ-
enced the values of examined efficiency in these coun-
tries. As we mentioned above, after eliminating the
extreme values of the individual variables, the average ef-
ficiency increased. It may also be affected by the fact that
the sample size has decreased significantly after eliminat-
ing extreme values. Effectively this can be formally stated
as follows that the extreme values may affect the level of
health system efficiency score. The elimination process
of outliers has led to higher homogeneity of the results,
as evidenced by the lower standard deviation values of
overall efficiency during the analysed period. For in-
stance, in 2016, variability decreased from 0.1057 to
0.0738. These findings reinforce the general belief that
the DEA models are sensitive to outliers. For these rea-
sons, the analysis of outliers in DEA models may be
desirable.
Using Malmquist Index (MI), we can further observe
the changes in the efficiency among countries over time.
The detailed specification of the calculation of MI is
given in the study by Färe et al. [56]. The MI values may
be greater than or less than 1. The MI higher than one
indicates that the efficiency in the monitored DMU has
improved over the reporting period. On the other hand,
the MI lower than one indicates that the efficiency has
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worsened over time. The overall MI can be decomposed
into two effects: The Frontier Shift (FS) effect and the
Catch-up (CU) effect. The FS effect describes an im-
provement in efficiency due to the innovation, while the
CU effect provides an improvement in efficiency due to
improved operations and management of the healthcare
system (or management of public health sub-division or
medical care sub-division). Table 7 shows MI results
Table 6 Comparison of the overall efficiency results before and after considering the deletion of outliers
DMU Overall efficiency score - all countries Overall efficiency score-reduced sample Total Efficiency Change
2000 2008 2016 2000 2008 2016 2000 2008 2016
AUS 0.7178 0.6642 0.6429 0.9998 0.8443 0.8627 39.29% 27.12% 34.19%
AUT 1 1 1
BEL 0.7453 0.9301 0.7541 0.797 0.9334 0.8668 6.94% 0.35% 14.94%
CAN 1 1 1
CZE 1 1 0.9002
DNK 0.6655 0.6295 0.6551 0.71 0.6716 0.6776 6.69% 6.69% 3.43%
EST 0.9373 0.7745 0.8453 1 1 1 6.69% 29.12% 18.30%
FIN 1 1 1 1 1 1 0.00% 0.00% 0.00%
FRA 1 1 1 1 1 1 0.00% 0.00% 0.00%
DEU 0.7355 1 1
GRC 0.9229 1 1
HUN 1 1 1 1 1 1 0.00% 0.00% 0.00%
CHL 1 1 1
ISL 0.867 0.7916 0.8221
IRL 0.7344 0.8987 0.8783 0.8661 1 1 17.93% 11.27% 13.86%
ISR 1 1 1
ITA 0.7372 0.8175 0.7339 1 1 1 35.65% 22.32% 36.26%
JPN 1 1 1
LVA 1 1 1 1 1 1 0.00% 0.00% 0.00%
LTU 1 1 0.8578 1 1 1 0.00% 0.00% 16.58%
LUX 1 1 1 1 1 1 0.00% 0.00% 0.00%
MEX 1 1 1
NLD 1 1 1 1 1 1 0.00% 0.00% 0.00%
NZL 0.697 0.7754 0.7781 0.9999 0.9999 0.9999 43.46% 28.95% 28.51%
NOR 0.9071 0.9328 0.8682 1 1 1 10.24% 7.20% 15.18%
POL 1 1 1 1 1 1 0.00% 0.00% 0.00%
PRT 1 1 1 1 1 1 0.00% 0.00% 0.00%
KOR 1 1 1
SVK 1 1 1
SVN 0.8853 1 1 0.9359 1 1 5.72% 0.00% 0.00%
ESP 1 1 1 1 1 1 0.00% 0.00% 0.00%
SWE 1 1 1 1 1 1 0.00% 0.00% 0.00%
CHE 0.9985 0.9999 0.9999 0.9998 1 1 0.13% 0.01% 0.01%
TUR 1 1 1
GBR 1 1 1 1 1 1 0.00% 0.00% 0.00%
USA 1 1 1 1 1 1 0.00% 0.00% 0.00%
Average 0.932 0.9504 0.9371 0.9699 0.9761 0.9742 4.07% 2.70% 3.96%
Standard deviation 0.1106 0.0999 0.1057 0.0742 0.0732 0.0738
Source: Prepared by authors
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with the assumption of a CRS. In a comprehensive
statement, there was an average 5% improvement in
OECD health performance between 2000 and 2016.
The progress in the overall total factor productivity
index was caused by the 16% growth in the relative
technical efficiency (CU effect) and negative
innovation (FS) effect by the 4%, which led to the
shift of production possibility frontier. The overall
progress was positively influenced by the progress of
19% in the case of the public health sub-division and
by the deterioration of 8% in the medical sub-
division. The progress in the MI index in the public
health sub-division was caused by the progress of
26% in the relative technical efficiency and the nega-
tive innovation effect by 5%. In the case of the med-
ical care sub-division, the deterioration was caused by
the decline in the relative technical efficiency by 8%
and the positive innovation effect by 1%. The frontier
shift effect representing the impact of innovation was
positive only within the medical care sub-division. We
can suppose that thanks to innovation in information
technologies, the medical care sub-division was able
to offer more appropriate services, enabling them to
take their services closer to patients and so increase
their efficiency. Overall, 25 OECD countries achieved
an improvement (MI > 1) in performance. On the
other hand, only nine countries recorded a decline
(MI < 1) over the reporting period: Lithuania, Slovakia,
Chile, the United Kingdom, Estonia, Norway, Poland,
Latvia and France. Israel and Belgium did not record
any change in performance during the reporting
period. The highest growth can be seen in the case of
Greece, which achieved an efficiency improvement of
21% between the years 2000 and 2016. On the other
hand, France achieved the highest decline of 10%. Fu-
ture research could extend the results of this work
towards a number of directions.
In a comprehensive assessment of OECD countries, an
improvement in the performance of 19% in the public
health sub-division, with a decrease in performance of
8% in the medical care sub-division, is evident. Figure 3
and Fig. 4 show a comparison of the Malmquist Index
levels within the public health and medical care sub-
divisions of OECD countries between 2000 and 2016 for
the DNDEA model with the assumption of CRS and
VRS, respectively.
The figures are divided into four quadrants based on
growth or a decline in performance in the public health
sub-division and medical care sub-division. The country
classification of the DNDEA model with CRS narrows to
two areas - the second and fourth quadrants. Turkey,
Korea, Germany, Luxembourg, the Netherlands and
Greece saw performance growth in both sub-divisions.
At the same time, these countries also saw an overall in-
crease in performance over the reporting period.
Belgium and Israel saw no increase or decrease in overall
performance over the period under review. These coun-
tries are part of the fourth quadrant. In these countries,
Table 7 The Malmquist Index levels for the DNDEA model with
CRS
DMU Overall Public health Medical care
MI CU FS MI CU FS MI CU FS
GRC 1.21 1.34 1.09 1.40 1.28 1.09 1.04 1.04 1
NLD 1.19 1.16 1.23 1.30 1.17 1.12 1.09 0.99 1.10
LUX 1.18 1.11 1.26 1.29 1.29 1 1.09 0.86 1.26
KOR 1.14 1.51 0.86 1.18 1.37 0.86 1.10 1.10 1
TUR 1.13 1.27 1.00 1.14 1.14 1 1.11 1.11 1
NZL 1.13 1.19 1.07 1.37 1.32 1.04 0.93 0.90 1.03
SVN 1.13 1.11 1.14 1.37 1.24 1.10 0.93 0.89 1.04
CAN 1.11 1.24 0.99 1.25 1.34 0.93 0.99 0.93 1.06
CZE 1.10 1.36 0.89 1.23 1.39 0.89 0.98 0.98 1
AUS 1.09 1.44 0.83 1.28 1.45 0.88 0.93 1.00 0.94
HUN 1.09 1.09 1.08 1.28 1.18 1.08 0.93 0.93 1
ISL 1.08 1.21 0.97 1.39 1.39 1 0.85 0.87 0.97
DEU 1.08 1.19 0.98 1.14 1.26 0.90 1.03 0.94 1.09
USA 1.08 1.20 0.97 1.24 1.24 1 0.94 0.97 0.97
ESP 1.07 1.12 1.03 1.25 1.21 1.03 0.92 0.92 1
IRL 1.07 1.08 1.06 1.26 1.24 1.01 0.91 0.87 1.05
JPN 1.06 1.13 1.00 1.27 1.27 1 0.89 0.89 1
ITA 1.05 1.20 0.93 1.16 1.28 0.91 0.96 0.94 1.02
CHE 1.04 1.21 0.90 1.15 1.27 0.90 0.95 0.95 1.00
PRT 1.04 1.23 0.89 1.21 1.36 0.89 0.90 0.90 1
AUT 1.04 1.08 1.00 1.17 1.17 1 0.93 0.93 1
MEX 1.02 1.04 1.00 1.16 1.16 1 0.90 0.90 1
SWE 1.01 0.98 1.04 1.11 1.11 1 0.92 0.88 1.04
FIN 1.01 1.02 1.00 1.25 1.25 1 0.81 0.81 1
DNK 1.01 1.00 1.02 1.26 1.19 1.06 0.81 0.84 0.96
ISR 1.00 0.96 1.05 1.13 1.13 1 0.89 0.84 1.05
BEL 1.00 1.14 0.87 1.11 1.29 0.87 0.89 0.89 1.01
LTU 0.99 1.17 0.85 1.13 1.33 0.85 0.88 0.88 1
SVK 0.99 1.16 0.84 1.04 1.23 0.84 0.94 0.94 1.00
CHL 0.99 0.97 1.00 1.07 1.07 1 0.91 0.91 1
GBR 0.98 1.12 0.86 1.08 1.26 0.86 0.89 0.89 1
EST 0.98 1.20 0.80 1.20 1.39 0.86 0.80 0.87 0.92
NOR 0.97 1.04 0.91 1.14 1.14 1 0.83 0.92 0.91
POL 0.97 1.15 0.81 1.04 1.29 0.81 0.90 0.90 1
LVA 0.96 1.16 0.79 1.12 1.31 0.86 0.82 0.88 0.92
FRA 0.90 1.22 0.67 1.01 1.44 0.70 0.81 0.84 0.96
Geometric mean 1.05 1.16 0.96 1.19 1.26 0.95 0.92 0.92 1.01
Source: Prepared by authors
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there has been a decline in performance in the medical
care sub-division and an increase in performance in the
public health sub-division.
Slovakia, Poland, Chile, the United Kingdom,
Lithuania, Norway, Latvia, Estonia and France experi-
enced an overall decline in performance over the report-
ing period, mainly related to a decline in the medical
care sub-division. Interestingly, there was no decline in
performance in the public health sub-division in any
country over the reporting period.
Table 8 shows the classification of countries based on
the MI and its components for CRS and VRS, which
show that in the case of the DNDEA model, the CRS
progression in performance in all countries (except
Sweden and Denmark) results from increased efficiency
levels.
In view of all that has been mentioned so far, the de-
composition of the Malmquist Index allows us to ex-
plore two areas: efficiency change (CU effect) and
technology change (FS effect) for each OECD country.
Fig. 3 The MI results at CRS. Note: Red indicates those countries that have achieved an overall decline in health performance over the reporting
period (i.e. MI < 1, regress). Grey indicates countries where there has been no overall change in health performance. Black indicates countries with
overall progress in healthcare performance (i.e. MI > 1, progress). Source: Prepared by authors
Fig. 4 The MI results at VRS. Note: Red indicates those countries that have achieved an overall decline in health performance over the reporting
period (i.e. MI < 1, regress). Grey indicates countries where there has been no overall change in health performance. Black indicates countries with
overall progress in healthcare performance (i.e. MI > 1, progress). Source: Prepared by authors
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Changes in the CU effect point to an increase in per-
formance in this area of 16% overall for all OECD coun-
tries within the reporting period, with the reported
result indicating a shift of these countries to the effi-
ciency frontier. Conversely, the average change in FS ef-
fect recorded a decline by 4% for OECD countries
implying that the efficiency frontier is shifting negatively,
which may cause further technological decline (regress).
These results agree well with existing studies, by Dimas
et al. [38] and Mitropoulos [41], on the results suggest-
ing progress in productivity in OECD countries, which is
related to the change in efficiency than the change in
technologies.
Discussion
The main objective of this study was to quantify and
compare the efficiency scores of OECD health systems
during 2000, 2008 and 2016 by applying the Dynamic
Network Data Envelopment Analysis in the sub-
divisions of public health and medical care provision.
Consequently, an examination of the efficiency of health
systems at macroeconomic and microeconomic levels, as
well as investigating the causal links between them and
their impact on overall efficiency, had been explored.
This research trajectory also benefits methodologically.
It is hoped that this study will lead to new insights into
the elimination of one of the disadvantages of traditional
DEA analyses - sensitivity to input and output variables’
selection (and outliers), a number of inputs and outputs,
measurement errors (for more details in the studies of,
e.g. [34–36, 42], or [80]), as well as on measurement var-
iations [37].
Healthcare is a complex heterogeneous system influ-
enced both by political decisions within the country and
by the health processes in different types of healthcare
facilities. Their quality and efficiency are also influenced
by the type of hospital ownership, financial flows linked
to therapeutic and diagnostic processes, geographical
and socio-economic determinants, population structure,
the political situation in the country, etc. Thus, investi-
gating efficiency in separate sub-divisions has enabled us
to identify the critical points of efficiency and create
space for the more efficient redistribution of available re-
sources in the health system than assessing the quality
of healthcare provided by patients. The input-oriented
DNDEA model was chosen to achieve the goal of this
study. This model was also applied by Färe et al. [55].
Our research is the first step towards a more profound
understanding of DNDEA analysis in the health system
consisting of two main sub-divisions: public health and
medical care sub-division, considering health-adjusted
life expectancy as the main output of public health sub-
division. The significance of HALE is described by sev-
eral authors in their studies (e.g. [58–60]). Although
there were some limitations in the form of missing data,
to solve this problem, Anderson et al. [27] recommend
using data closest to the reference year or the period for
which the analysis is realised. This issue should be antic-
ipated and addressed in future studies.
The analyses’ results show many interesting findings
that may be interpreted both in a comprehensive evalu-
ation of the efficiency of health systems and in the indi-
vidual divisions. Subsequently, they may compare the
macroeconomic and microeconomic spheres in this sys-
tem. The main achievements, including contributions,
may be summarised as follows.
The analysis results for the public health sub-division,
medical care sub-division and overall health system for
OECD countries under the assumption of CRS indicate
that the average overall efficiency was 0.8801 in 2000,
0.8807 in 2008 and 0.8472 in 2016. According to the
achieved score, we can mark as efficient in all three
years: Austria, Finland, Chile, Japan, Mexico, and
Turkey. The favourable development in these countries
could be influenced by healthcare reforms taken in spe-
cified countries during the years 2000–2012. When we
look at the efficiencies of sub-divisions, we can see that
the average efficiency of the public health sub-division
Table 8 Profile for OECD countries based on the Malmquist Index values and its components




– SWE, DNK KOR, CAN, CZE, AUS, ISL, DEU, USA,
ITA, CHE, PRT, FIN, TUR, JPN, AUT, MEX
GRC, NLD, LUX, NZL,
SVN, HUN, ESP, IRL
Productivity regress
M < 1






– – KOR, TUR, AUS, CAN, AUT, NLD, ESP,
ISL, FRA, PRT, ISR, JPN, EST, LUX




LVA, DNK, SWE, USA, SVK,
GBR, POL, HUN, MEX, CHL, FIN
BEL NOR, LTU, CZE –
Source: Prepared by authors
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was 0.8836 in 2000, 0.8723 in 2008 and 0.8051 in 2016.
In the medical care sub-division, the average was 0.8766
in 2000, 0.8891 in 2008 and 0.8893 in 2016. Comparing
the results, we can say that the countries tend to be
more efficient within the medical care sub-division.
The analysis results under the assumption of VRS in-
dicate that the average overall efficiency was 0.9320 in
2000, 0.9504 in 2008 and 0.9371 in 2016. According to
the achieved score, we can mark as inefficient in all
three years: Australia, Belgium, Denmark, Estonia, Israel,
Ireland, Italy, New Zealand, Norway and Switzerland.
When we look at the efficiencies of sub-divisions, we
can see that the average efficiency of the public health
sub-division was 0.9334 in 2000, 0.9598 in 2008 and
0.9382 in 2016. In the medical care sub-division, the
average was 0.9305 in 2000, 0.9410 in 2008 and 0.9360
in 2016. When we compare the level of public health
sub-division and medical care sub-division efficiency
score, we can see that the efficiency of the public health
sub-division in 2016 was higher than medical care sub-
division only in Australia, Belgium, Denmark, Iceland,
Italy, Norway and Switzerland. The medical care sub-
division was more efficient than the public health sub-
division in the Czech Republic, Estonia, Ireland,
Lithuania, New Zealand, and the United Kingdom. In
other countries, both divisions were efficient in 2016.
As it was mentioned in the literature review some au-
thors prefer to use the model under the constant returns
to scale assumption (e.g. [2, 10, 16–18, 32, 37], or [41]),
while others prefer variable returns to scale assumption
(e.g. [11, 15, 20, 34], or [36]) presenting the advantages
of both assumptions. As the contribution of this paper,
we compare both approaches when variables are used in
ratio form. We apply a non-parametric test for the
equality of distributions presented by [81]. According to
the density test results (T-statistics = 14.57; p-value =
2.22e-16), we can say that there are no significant differ-
ences between the DNDEA model under the constant
returns to scale and variable returns to scale assumption.
This way, we can verify the results of previous studies.
In the case of ratio variables, the VRS model can be used
as ratios can eliminate the size differences between the
analysed countries.
We applied the input-oriented model to find out how
the country could set its inputs effectively to reach given
outputs. We analysed the optimal reduction in alcohol
and tobacco consumption in the public health area, lead-
ing to given health-adjusted life expectancy in the speci-
fied country. The average alcohol consumption in 2000
was 9.475 l per capita aged 15 years and older, and to-
bacco consumption was 26.0806 per capita aged 15 years
and over. The positive development could be seen as in
2016, the levels of indicators were only 8.9083 and
18.5722. The results pointed to the fact that there is still
space for reduction of alcohol and tobacco consumption.
According to the results at the given level of HALE, it is
necessary to reduce the alcohol consumption by 6.85%
and reduce the tobacco consumption by 4.59% on aver-
age. The results in the medical care area pointed to the
fact that, on average, there is still room for more effect-
ive use of technologies and employees. The significant
positive development in the equipment of the health sec-
tor could be seen during the analysed period. While in
2000, there were only 16.1 computer tomography de-
vices per 1000,000 inhabitants, in 2016, the average
number of devices was 25.9. Also, the number of em-
ployees increased from 10 doctors and nurses in health
care calculated per 1000 inhabitants to 12.5. But it is im-
portant to say that a lower value of technologies and em-
ployees would also be sufficient at the given level of
discharges and consultations. It indicates that after the
period of increased investment into the technologies, it
is also important to increase their effective usage in the
form of an increased rate of their use in the diagnosis
and treatment of the widest possible range of diseases.
The positive impact of investment into the technologies
and political decisions could be seen in the increasing
number of screenings and increasing immunisation, and
decreasing number of new cancer cases and decreasing
infant mortality. The results of the analysis pointed to
the fact that there is still space to improve also these in-
dicators by a 0.27% increase in the case of immunisation,
by 3% increase in the case of screenings, by 8% decrease
in infant mortality and 3% decrease in new cancer cases
(in average).
The DEA models are sensitive to extreme values (out-
liers) [54]. Thus, an analysis that focused on extreme
values of inputs and outpust had been realised. The re-
sults demonstrated in this work may have implications
for understanding the sensitivity of DEA models to out-
liers. With box-plot analysis, the number of OECD
countries has reduced to 23 countries. The average effi-
ciency increased by around 4% after the deviations were
excluded. The presence of extremely low or extremely
high inputs and outputs affect the efficiency score. We
could speculate that this increase in efficiency could be
due to a significant reduction in the research sample.
The elimination of outliers led to a higher homogeneity
of the results, which is confirmed by the lower standard
deviation results. In 2016, variability decreased from
0.1057 to 0.0738.
By applying the Malmquist Index, the changes in the
efficiency of countries over time were observed. In a
comprehensive assessment, the performance in OECD
countries in the health sector improved by 5% on aver-
age. The progress in the overall total factor productivity
index was caused by the 16% growth in the relative tech-
nical efficiency (CU effect) and negative innovation (FS)
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effect by the 4%, which led to the shift of production
possibility frontier.
Improvements in performance in several countries
were mainly due to improvements in the public health
sub-division (by 19%), while in the medical care sub-
division, there was a decrease in performance (by 8%).
The results of the Malmquist Index and its decomposi-
tions on the DNDEA model with the assumption of a
CRS allowed identifying countries with performance
growth in both sub-divisions, including Turkey, Korea,
Germany, Luxembourg, the Netherlands and Greece. On
the other hand, Slovakia, Poland, Chile, the United King-
dom, Lithuania, Norway, Latvia, Estonia and France re-
corded a decline in performance over the reporting
period, mainly related to a decline in medical care sub-
division. There was no decline in public health sub-
division performance in any country during the report-
ing period.
The results of the Malmquist Index for the DNDEA
model at VRS point to several changes in the ranking of
countries. There has been an increase in the number of
countries from 9 to 15, which achieved an overall de-
cline in health performance in the reporting period,
mainly due to a decline in the medical care sub-division.
Changes due to the CU effect point to an increase in
performance in this area of 16% for OECD countries. In
contrast, the average change due to the FS effect re-
corded a decrease of 4%. These results agree well with
Dimas et al. [38] and Mitropoulos [41]. In their studies,
these authors confirmed that the progression in product-
ivity of OECD countries is related to a change in effi-
ciency rather than a technological change.
This combination of findings supports the conceptual
premise that gives us an interesting insight into the im-
pact of individual factors on the efficiency of health sys-
tems in OECD countries and highlights the need for
systematic development of a methodological platform
for assessing health efficiency. National registers of indi-
vidual countries are not sufficiently compatible to carry
out comparative analyses as well as to examine the rela-
tionship of inputs and outputs within the health system.
The heterogeneity of countries’ health systems, their
sensitivity to policy changes, the evolution of the demo-
graphic structure and their impact on pension systems,
globalisation trends, migration, integration, political,
economic and epidemiological crises will require a spe-
cific approach to exploring and identifying new factors
affecting their effectiveness. This will also require a
broader framework of international cooperation based
on international networking with the development of
mechanisms to eliminate inequalities in the health sys-
tems of the countries. Taken together, this remains an
important priority for the health policies of OECD coun-
tries. This justifies the strong importance of national and
international research studies to assess the effectiveness
of health systems and puts pressure on the permanent,
systematic development of methodological platforms
and data systems in national and international registers.
Conclusions
The efficiency of health systems is a long-term research
domain of experts and professionals worldwide. Detect-
ing resources of the inefficiency of the health system and
defining optimal measures requires a long-term concep-
tual examination of all dimensions of the health system
and strong cooperation between research teams and pol-
icymakers. In addition, changes in economies and many
socio-economic and political impacts raise intriguing
questions regarding the nature and extent of methodo-
logical platforms for assessing the efficiency of health
systems.
In this study, the input-oriented DNDEA model with
the assumption of a CRS and VRS was used to estimate
the efficiency of health systems in OECD countries dur-
ing 2000, 2008 and 2016. The overall health system effi-
ciency for OECD countries under the assumption of
CRS indicates that the average overall efficiency was
0.8801 in 2000, 0.8807 in 2008 and 0.8472 in 2016. The
overall efficiency under the assumption of VRS indicates
that the average efficiency was 0.9320 in 2000, 0.9504 in
2008 and 0.9371 in 2016. Comparing the results, we can
say that the countries tend to be more efficient within
the medical care sub-division than within the public
health sub-division under both approaches.
By applying the Malmquist Index and its decomposi-
tions, significant changes in efficiency over time were
observed. The 25 OECD countries have improved their
performance levels over the reporting period. Partially,
there was an improvement of 19% in the public health
sub-division and a decrease of 8% in the medical care
sub-division across countries with the assumption of
constant returns to scale. Several other factors are also
crucial in our analysis. On the one hand, it is a selection
of inputs and outpust. In research studies, there are sev-
eral inputs and outputs in the public health sub-division,
and medical care sub-division, which may be used in a
similar analysis using DNDEA models or classical DEA
models. On the other hand, the analytical outputs repre-
sent a combination of conventional and unconventional
methods of measuring health efficiency and provide
many ideas for subsequent research in this field.
Despite the success demonstrated, a significant limita-
tion of this study is the availability and complexity of da-
tabases. The inconsistency in the publication and
updating of data partly limits the analytical possibilities
and the subsequent development of methodologies. To
realise multi-divisional analyses of the efficiency of
health systems, it will be necessary to have access to
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deeper structured data and databases and ensure their
interconnection at a national and international level.
Future trends are clear – health expenditure will in-
crease in all OECD countries due to demographic age-
ing. This development will be determined by
introducing advanced technologies (biotechnologies,
nanotechnologies), innovative treatment practices and
processes. However, a serious dilemma will be the long-
term adjustment of the level of resources with the real
costs and extent of healthcare.
As the number of older people increases, more elderly
patients requiring specialised healthcare and long-term
healthcare will need to be treated. Changes in the health
behaviour and the current lifestyle of individuals support
negative developments in the number of chronic dis-
eases and avoidable mortality. From a macro-economic
point of view, the serious question of the sustainability
of the health and social system in the country is coming
to mind.
This also creates intense pressures for the further de-
velopment of methodologies that would examine effi-
ciency in the health sector and reveal its other
determinants. Also, it would support the development of
international benchmarks in this area and encourage the
implementation of international comparative analyses.
These are essential for properly setting health policies in
countries and drafting regional and national health sus-
tainable plans. Tackling this issue requires an ongoing
performance of comparative analyses and active policy
concepts to eliminate health inequalities. It is not pos-
sible to evaluate them without performing high-quality
comparative analyses of the efficiency of health systems
in countries and creating international benchmarks.
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